Market Share of Global Melanoma Diagnostics and Therapeutics Industry
The market is highly competitive, with many key players involved in market expansion, partnerships, new product development, and R&D to increase market penetration. There are also several products under clinical trials which are expected to receive approval and thus, the market is likely to continue witnessing high competitive rivalry over the forecast period.
Melanoma Diagnostics & Therapeutics Market Leaders
Abbott Laboratories
Amgen, Inc.
Bristol-Myers Squibb
Novartis AG
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order
